April 30, 2018 / 6:57 AM / 3 months ago

BRIEF-Sinclair Pharma FY Sales Of £45.3 Million

April 30 (Reuters) - Sinclair Pharma PLC:

* FY GROSS PROFIT INCREASED 23% TO £32.9 MILLION

* SINCLAIR PHARMA - EX US, BOARD EXPECTS TO DELIVER AT LEAST MID-TEENS PERCENTAGE REVENUE GROWTH IN 2018 WITH HIGH MARGINAL PROFITABILITY

* AS IN 2017 GROUP’S REVENUES WILL BE SECOND HALF WEIGHTED IN 2018

* AT ADJUSTED EBITDA LEVEL, BOARD EXPECTS GROUP TO REMAIN PROFITABLE IN 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below